• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并双环[3.2.1]辛烯衍生物作为一类新型的胆碱酯酶抑制剂。

Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors.

机构信息

Institute for Medical Research and Occupational Health, Ksaverska Cesta 2, 10000 Zagreb, Croatia.

Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev trg 19, 10000 Zagreb, Croatia.

出版信息

Molecules. 2020 Oct 22;25(21):4872. doi: 10.3390/molecules25214872.

DOI:10.3390/molecules25214872
PMID:33105595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7659976/
Abstract

A library of amine, oxime, ether, epoxy and acyl derivatives of the benzobicyclo[3.2.1]octene were synthesized and evaluated as inhibitors of both human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The majority of the tested compounds exhibited higher selectivity for BChE. Structural adjustment for AChE seems to have been achieved by acylation, and the furan ring opening of furo-benzobicyclo[3.2.1]octadiene results for compound with the highest AChE affinity (IC = 8.3 µM). Interestingly, its analogue, an oxime ether with a benzobicyclo[3.2.1]-skeleton, compound was one of the most potent BChE inhibitors in this study (IC = 31 µM), but not as potent as , an ether derivative of the benzobicyclo[3.2.1]octene with an additional phenyl substituent (IC = 17 µM). Therefore, we identified several cholinesterase inhibitors with a potential for further development as potential drugs for the treatment of neurodegenerative diseases.

摘要

合成了一系列苯并双环[3.2.1]辛烯的胺、肟、醚、环氧化物和酰基衍生物,并评估了它们对人乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的抑制作用。大多数测试化合物对 BChE 表现出更高的选择性。似乎通过酰化实现了对 AChE 的结构调整,而呋喃环开环则导致呋喃苯并双环[3.2.1]辛二烯化合物 具有最高的 AChE 亲和力(IC = 8.3 µM)。有趣的是,其类似物,即具有苯并双环[3.2.1]骨架的肟醚化合物 ,是本研究中最有效的 BChE 抑制剂之一(IC = 31 µM),但其效力不及苯并双环[3.2.1]辛烯的醚衍生物 ,后者具有额外的苯基取代基(IC = 17 µM)。因此,我们确定了几种具有进一步开发潜力的胆碱酯酶抑制剂,作为治疗神经退行性疾病的潜在药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/0b5f5b0a8c68/molecules-25-04872-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/4741be110151/molecules-25-04872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/8641c4dbca2f/molecules-25-04872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/726009c5ae99/molecules-25-04872-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/9b023ab08024/molecules-25-04872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/844e29d96555/molecules-25-04872-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/89b445b22a45/molecules-25-04872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/868bfdbb32c4/molecules-25-04872-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/c05ad2b2984f/molecules-25-04872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/b37b7285ef9d/molecules-25-04872-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/8abd5126db2c/molecules-25-04872-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/d12972d8f782/molecules-25-04872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/fc19606e3089/molecules-25-04872-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/e03398c54cda/molecules-25-04872-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/efea728d585f/molecules-25-04872-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/a644d47e5c72/molecules-25-04872-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/5293ac532b0e/molecules-25-04872-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/50c3d2a4799e/molecules-25-04872-g012a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/1b816064a82a/molecules-25-04872-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/d87bdbc2a277/molecules-25-04872-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/0b5f5b0a8c68/molecules-25-04872-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/4741be110151/molecules-25-04872-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/8641c4dbca2f/molecules-25-04872-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/726009c5ae99/molecules-25-04872-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/9b023ab08024/molecules-25-04872-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/844e29d96555/molecules-25-04872-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/89b445b22a45/molecules-25-04872-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/868bfdbb32c4/molecules-25-04872-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/c05ad2b2984f/molecules-25-04872-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/b37b7285ef9d/molecules-25-04872-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/8abd5126db2c/molecules-25-04872-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/d12972d8f782/molecules-25-04872-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/fc19606e3089/molecules-25-04872-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/e03398c54cda/molecules-25-04872-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/efea728d585f/molecules-25-04872-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/a644d47e5c72/molecules-25-04872-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/5293ac532b0e/molecules-25-04872-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/50c3d2a4799e/molecules-25-04872-g012a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/1b816064a82a/molecules-25-04872-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/d87bdbc2a277/molecules-25-04872-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7a/7659976/0b5f5b0a8c68/molecules-25-04872-g014.jpg

相似文献

1
Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors.苯并双环[3.2.1]辛烯衍生物作为一类新型的胆碱酯酶抑制剂。
Molecules. 2020 Oct 22;25(21):4872. doi: 10.3390/molecules25214872.
2
Design, synthesis and cholinesterase inhibitory properties of new oxazole benzylamine derivatives.新型噁唑苄胺衍生物的设计、合成及乙酰胆碱酯酶抑制活性。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):460-467. doi: 10.1080/14756366.2019.1707197.
3
Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.类黄酮醇和 4-硫代类黄酮醇作为潜在的乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的研究:合成、构效关系和分子对接研究。
Bioorg Chem. 2019 Oct;91:103124. doi: 10.1016/j.bioorg.2019.103124. Epub 2019 Jul 12.
4
Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.探索基于吲哚的噻二唑衍生物作为有效的乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂。
Int J Biol Macromol. 2021 Oct 1;188:1025-1036. doi: 10.1016/j.ijbiomac.2021.08.065. Epub 2021 Aug 11.
5
Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.设计并合成了一些以苯并嘧啶为核心环的新型羧酰胺和丙酰胺衍生物,并研究了它们对体外乙酰胆碱酯酶和丁酰胆碱酯酶的抑制潜力。
Bioorg Chem. 2018 Sep;79:235-249. doi: 10.1016/j.bioorg.2018.05.006. Epub 2018 May 8.
6
Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.新型联苯双磺酰胺类乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂的合成、生物评价及分子模拟研究。
Bioorg Chem. 2016 Feb;64:13-20. doi: 10.1016/j.bioorg.2015.11.002. Epub 2015 Nov 10.
7
Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.新型乙酰胆碱酯酶抑制剂的合成及混合 SAR 性质建模。
Int J Mol Sci. 2021 Mar 26;22(7):3444. doi: 10.3390/ijms22073444.
8
Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.新型 N-苄基吡啶鎓部分与芳基异恶唑衍生物连接作为选择性丁酰胆碱酯酶抑制剂的研究:合成、生物评价和对接研究。
Bioorg Chem. 2019 Nov;92:103192. doi: 10.1016/j.bioorg.2019.103192. Epub 2019 Aug 10.
9
Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.新型亚芳基氨基噻唑基乙酮衍生物的合成、表征及胆碱酯酶抑制研究
Med Chem. 2017;13(7):648-653. doi: 10.2174/1573406413666170306113347.
10
Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.苯并呋喃取代苯并噻唑啉衍生物的设计、合成及作为丁酰胆碱酯酶抑制剂和抗菌剂的生物评价。
Bioorg Med Chem. 2018 Jul 23;26(12):3076-3095. doi: 10.1016/j.bmc.2018.02.049. Epub 2018 Mar 1.

引用本文的文献

1
Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.维生素 B6 二肟类似物作为胆碱酯酶配体的潜力。
Int J Mol Sci. 2022 Nov 2;23(21):13388. doi: 10.3390/ijms232113388.

本文引用的文献

1
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.基于尿嘧啶部分的新型乙酰胆碱酯酶抑制剂,可能用于治疗阿尔茨海默病。
Molecules. 2020 Sep 12;25(18):4191. doi: 10.3390/molecules25184191.
2
The history of acetylcholinesterase inhibitors in the treatment of myasthenia gravis.乙酰胆碱酯酶抑制剂在重症肌无力治疗中的历史。
Neuropharmacology. 2021 Jan;182:108303. doi: 10.1016/j.neuropharm.2020.108303. Epub 2020 Sep 9.
3
Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases.
有机磷酸酯抑制胆碱酯酶的三联结合重活化剂的对映体拆分、体外测试及结构表征
Biochem J. 2020 Aug 14;477(15):2771-2790. doi: 10.1042/BCJ20200192.
4
The effects of acetylcholinesterase inhibitors on morbidity after general anesthesia and surgery.乙酰胆碱酯酶抑制剂对全麻和手术后发病率的影响。
Neuropharmacology. 2020 Aug 15;173:108134. doi: 10.1016/j.neuropharm.2020.108134. Epub 2020 May 19.
5
Design, synthesis and cholinesterase inhibitory properties of new oxazole benzylamine derivatives.新型噁唑苄胺衍生物的设计、合成及乙酰胆碱酯酶抑制活性。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):460-467. doi: 10.1080/14756366.2019.1707197.
6
Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.4-氨基喹啉类化合物作为人乙酰胆碱酯酶和丁酰胆碱酯酶可逆抑制剂的结构特征。
Chem Biol Interact. 2019 Aug 1;308:101-109. doi: 10.1016/j.cbi.2019.05.024. Epub 2019 May 15.
7
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold.基于金鸡纳生物碱骨架的选择性丁酰胆碱酯酶抑制剂的设计与评价。
PLoS One. 2018 Oct 5;13(10):e0205193. doi: 10.1371/journal.pone.0205193. eCollection 2018.
8
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.胆碱能系统在阿尔茨海默病的病理生理学和治疗中的作用。
Brain. 2018 Jul 1;141(7):1917-1933. doi: 10.1093/brain/awy132.
9
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.用于治疗痴呆症状的乙酰胆碱酯酶抑制剂——安全性评估
Expert Opin Drug Saf. 2017 Sep;16(9):1009-1019. doi: 10.1080/14740338.2017.1351540. Epub 2017 Jul 12.
10
Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.基于间苯二酚、儿茶酚和水杨苷的支气管扩张β2激动剂作为人胆碱酯酶活性的抑制剂。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):789-797. doi: 10.1080/14756366.2017.1326109.